Cipla signs agreement with Novartis for diabetes therapy Galvus range
Galvus has the potential to contribute significantly to Cipla’s portfolio in the diabetes care continuum space with reported sales of Rs. 268 crore
Galvus has the potential to contribute significantly to Cipla’s portfolio in the diabetes care continuum space with reported sales of Rs. 268 crore
Urges everyone to follow COVID Appropriate Behaviour and curb any misinformation
He mentioned that Thyroid disorders are a common health problem in Jammu and Kashmir
MoU signed between AIIA and University of Amrita Vishwa Vidhyapeetham for collaboration in the field of Research and Academics in Ayurveda
Envelta is the company’s non-opioid pain product candidate for acute and chronic pain
Microsoft Cloud for Healthcare and Cognizant’s TriZetto healthcare products aim to enhance transparency for consumers and increase interoperability for providers and payers
The C20 is an engagement group of the G20 that focuses on Civil issues and looks to promote sustainable growth and financial stability.
FDA’s NME approvals declined substantially in 2022, causing overall New Drug Application (NDA) approvals to drop
The milestone of operating continuously a very complex system for over two years has demonstrated the effectiveness of integrated laboratory automation solutions
Government hospitals like AIIMS, KGMC & many more as per day OPD patients are 18-25 thousand
Subscribe To Our Newsletter & Stay Updated